These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevention of thrombosis with prostaglandin E1 in a patient with catastrophic antiphospholipid syndrome. Ozaki M; Ogata M; Yokoyama T; Kawasaki T; Shigematsu A; Sata T Can J Anaesth; 2005 Feb; 52(2):143-7. PubMed ID: 15684253 [TBL] [Abstract][Full Text] [Related]
36. Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation. Oka S; Ono K; Nohgawa M Intern Med; 2017; 56(10):1207-1212. PubMed ID: 28502938 [TBL] [Abstract][Full Text] [Related]
37. Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Shapira I; Andrade D; Allen SL; Salmon JE Arthritis Rheum; 2012 Aug; 64(8):2719-23. PubMed ID: 22354668 [TBL] [Abstract][Full Text] [Related]
38. Catastrophic manifestation of the antiphospholipid syndrome. Schaar CG; Ronday KH; Boets EP; van der Lubbe PA; Breedveld FC J Rheumatol; 1999 Oct; 26(10):2261-4. PubMed ID: 10529152 [TBL] [Abstract][Full Text] [Related]
39. [Catastrophic antiphospholipid syndrome during pregnancy]. Derks M; Oudijk MA; van der Made F; van den Born BJ; van der Post JA Ned Tijdschr Geneeskd; 2011; 155(18):A3263. PubMed ID: 21771361 [TBL] [Abstract][Full Text] [Related]